Vimarsana
Biggest News Aggregation in the World

Clin Pharm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clin Pharm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clin Pharm Today - Breaking & Trending Today

Cardiovascular Disease Risk Management During COVID-19: In-Person vs Virtual Visits - Vimarsana News

Cardiovascular Disease Risk Management During COVID-19: In-Person vs Virtual Visits

This article compares cardiovascular disease risk management in community clinics during the COVID-19 pandemic among patients for whom primary care was delivered mostly in person vs mostly virtually.

Source: ajmc.com
Pharmacy-Led Medication Reconciliation Is Best Practice - Vimarsana News

Pharmacy-Led Medication Reconciliation Is Best Practice

The TJC and IHI advocate for medication reconciliation at all transitions of care.

Professors Anna Schwedenman¹ and Sarfaraz Niazi² awarded a $2 Million FDA grant to create novel analytical methods to reduce the cost of developing biosimilars - Vimarsana News

Professors Anna Schwedenman¹ and Sarfaraz Niazi² awarded a $2 Million FDA grant to create novel analytical methods to reduce the cost of developing biosimilars

CHICAGO, Nov. 22, 2022 /PRNewswire/ -- To reduce the cost of development of the approval of biosimilars, the FDA is encouraging the introduction of novel analytical methods to establish biosimilarity,

Source: wsiltv.com
Professor Sarfaraz Niazi Convinces the US Senate to Vote on Removing Interchangeable Status of Biosimilars. - Vimarsana News

Professor Sarfaraz Niazi Convinces the US Senate to Vote on Removing Interchangeable Status of Biosimilars.

/PRNewswire/ -- The US is the only country with two classes of biosimilars; an interchangeable status is awarded to approved biosimilars after extensive...

Patients access to medicines - healthcare system in Kenya - Vimarsana News

Patients access to medicines - healthcare system in Kenya

Facilitating the entry of SF medicines into the legitimate pharmaceutical supply chain and discuss their impact on patient access to medicines